On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Janssen (United States)

InstitutionResearch output, impact & collaborations

Janssen (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Janssen (United States)?

ScholarIQrecord summary

Janssen (United States) is a research organisation in Hopewell, US. OpenAlex records 13,086 works and 1,681,745 citations for it. 2,779 researchers list it as their most recent affiliation.

How many works does Janssen (United States) have?

ScholarIQindexed works

Janssen (United States) has 13,086 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Janssen (United States) have?

ScholarIQcitation count

Janssen (United States) has 1,681,745 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Janssen (United States)?

ScholarIQresearcher count

Janssen (United States) has 2,779 researchers in the ScholarIQ index.

What is the average h-index at Janssen (United States)?

ScholarIQavg h-index

Janssen (United States) has an average h-index of 44 in OpenAlex.

What is the ROR of Janssen (United States)?

ScholarIQror

The ROR for Janssen (United States) is on the source record.

What is the OpenAlex record for Janssen (United States)?

ScholarIQopenalex

The OpenAlex for Janssen (United States) is on the source record.

Who are the most-cited researchers behind Janssen (United States)?

ScholarIQtop researchers by citations
1
Stephen C. Beck · DNA Repair Mechanisms
18 works24,260 citations
2
Enchi Liu · Alzheimer's disease research and treatments
114 works19,854 citations
3
Glenn S. Cowley · RNA modifications and cancer
259 works19,656 citations
4
Guohua Pan · Cell death mechanisms and regulation
71 works19,639 citations
5
Paul Stang · Migraine and Headache Studies
181 works18,242 citations

What are the most-cited papers on Janssen (United States)?

ScholarIQmost cited works
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, Guohua Pan, Daniel E. Singer, Werner Hacke, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, John F. Paolini, Scott D. Berkowitz, Keith A.A. Fox, Robert M. Califf
New England Journal of Medicine. 20119,441 CitationsOPEN ACCESS
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato, Kevin M. Marks, Yoav D. Shaul, Michael E. Pacold, Dohoon Kim, Kıvanç Birsoy, Shalini Sethumadhavan, Hin-Koon Woo, Hyun Gyung Jang, Abhishek Jha, Walter W. Chen, Francesca G. Barrett, Nicolas Stransky, Zhi-Yang Tsun, Glenn S. Cowley, Jordi Barretina, Nada Y. Kalaany, Peggy P. Hsu, Kathleen Ottina, A. M. C. Chan, Bingbing Yuan, Levi A. Garraway, David E. Root, Mari Mino–Kenudson, Elena F. Brachtel, Edward M. Driggers, David M. Sabatini
Nature. 20111,735 CitationsOPEN ACCESS
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter Higgins, Jan Wehkamp, Brian G. Feagan, Michael Yao, Marek Karczewski, Jacek Karczewski, Nicole Pezous, Stephan Bek, Gerard Bruin, Bjoern Mellgard, C Berger, Marco Londei, Arthur P. Bertolino, Gervais Tougas, Simon Travis, for the Secukinumab in Crohn's Disease Study Group
Gut. 20121,511 CitationsOPEN ACCESS
Reduced Paneth cell α-defensins in ileal Crohn's disease
Jan Wehkamp, Nita H. Salzman, Edith Porter, Sabine Nuding, Michael Weichenthal, Robert E. Petras, Bo Shen, Elke Schaeffeler, Matthias Schwab, Rose Linzmeier, Ryan W. Feathers, Hiutung Chu, Heriberto Lima, Klaus Fellermann, Tomas Ganz, Eduard F. Stange, Charles Bevins
Proceedings of the National Academy of Sciences. 2005968 CitationsOPEN ACCESS
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
Jan Wehkamp, Jürgen Harder, Michael Weichenthal, Matthias Schwab, Elke Schäffeler, Miriam Schlee, K Herrlinger, Andreas Stallmach, Florian Noack, Péter Fritz, J.‐M. Schröder, Charles Bevins, Klaus Fellermann, Eduard F. Stange
Gut. 2004798 CitationsOPEN ACCESS

How much of the research on Janssen (United States) is open access?

ScholarIQopen access share
92%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
58%
Closed
8%

Related on ScholarIQ

470M+ articles · 14-day free trial